Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trial
Authors:
- Jonathan R.T. DavidsonJDJonathan R.T. Davidson
- Hans-Ulrich WittchenHWHans-Ulrich Wittchen
- Pierre-Michel LlorcaPLPierre-Michel Llorca
- Janelle EricksonJEJanelle Erickson
- Michael DetkeMDMichael Detke
- Susan G. BallSBSusan G. Ball
- James M. RussellJRJames M. Russell
- 1 September 2008
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 18 (9) , 673-681
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trialInternational Clinical Psychopharmacology, 2007
- Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trialsCurrent Medical Research and Opinion, 2007
- Efficacy of Duloxetine for the Treatment of Generalized Anxiety DisorderThe Primary Care Companion For CNS Disorders, 2007
- DuloxetineJournal of Clinical Psychopharmacology, 2006
- Anxiety disorders and suicidal behaviours in adolescence and young adulthood: findings from a longitudinal studyPsychological Medicine, 2006
- Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective StudyAmerican Journal of Psychiatry, 2005
- Length of Therapy with Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants in AustraliaAustralian & New Zealand Journal of Psychiatry, 2004
- Phenomenology and Course of Generalised Anxiety DisorderThe British Journal of Psychiatry, 1996
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983